Studies of migraine’s many triggers offer paths to new therapies

arstechnica.com

Studies of migraine’s many triggers offer paths to new therapies

arstechnica.com

free@rss.ponder.catBM to

Ars Technica - All Content@rss.ponder.catEnglish · 2 years ago

One class of drugs has already found success in treating the painful, common attacks.

You must log in or # to comment.

Chat

Ars Technica - All Content@rss.ponder.cat

arstechnica_index@rss.ponder.cat

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !arstechnica_index@rss.ponder.cat

Community locked: only moderators can create posts. You can still comment on posts.

All Ars Technica stories

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

0 users / day
0 users / week
0 users / month
1 user / 6 months
1 local subscriber
225 subscribers
4 Posts
1 Comment
Modlog